SavedAdd your journal

Journals / Çukurova Anestezi ve Cerrahi Bilimler Dergisi / 2021 / Cilt: 4 - Sayı: 2

Rekürren Laringeal Papillomatoziste Güncel Tedavi ve Yönetim

Elvan ONAN
Pages
131–137
Publication Date
2021-08-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Adjuvant treatment options are planned in cases that cannot be controlled by surgical treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Özet: Laringeal papillomlar, solunum yolunun farklı yerlerinde epitel hücrelerinde aşırı büyümeye neden olan viral bir enfeksiyonun neden olduğu iyi huylu bir lezyondur.
📊
Key Findings & Data:Etken Human Papilloma virüsüdür.
💡
Conclusion & Impact:Adjuvant treatment options are planned in cases that cannot be controlled by surgical treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:rekürren laringeal papillomatozis · sidofovir · human papilloma virüs

Özet

Özet: Laringeal papillomlar, solunum yolunun farklı yerlerinde epitel hücrelerinde aşırı büyümeye neden olan viral bir enfeksiyonun neden olduğu iyi huylu bir lezyondur. Etken Human Papilloma virüsüdür. Standart tedavi yöntemi lezyonların cerrahi olarak eksizyonudur. lazer, mikrodebrider, soğuk cerrahi aletler veya bunların kombinasyonu kullanılarak genel anestezi altında operasyon gerçekleştirilir. Cerrahi tedavi ile kontrol altına alınamayan olgularda adjuvan tedavi seçenekleri planlanır. Abstract: Recurrent laryngeal papillomas are the benign lesion caused by a viral infection with overgrowth of epithelial cells in different parts of the respiratory tract. It is caused by the human papillomavirus. Standard treatment method is surgical excision of the lesions. Laser, microdebrider, cold surgical instruments or combinations can be used in operation under general anesthesia. Adjuvant treatment options are planned in cases that cannot be controlled by surgical treatment.

🔖

Cite This Article

ONAN, E. (2021). Rekürren Laringeal Papillomatoziste Güncel Tedavi ve Yönetim. Çukurova Anestezi ve Cerrahi Bilimler Dergisi, Cilt: 4 - Sayı: 2, 131–137. https://ajindex.com/articles/483839

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Abramson AL, Steinberg BM, Winkler B. Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope 1987
  2. 678–685 2. Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Dev Pathol 2001
  3. 68–72. 3. Nebesio CL, Mirowski GW, Chuang TY. Human papillomavirus: clinical significance and malignant potential. Int J Dermatol 2001
  4. 373– 379. 4. Silverberg MJ, Thorsen P, Lindeberg H, Ahdieh-Grant L, Shah KV. Clinical course of recurrent respiratory papillomatosis in danish children. Arch Otolaryngol Head Neck Surg 2004
  5. 130(6):711–716 5. Siegel B, Smith LP. Management of complex glottic stenosis in children with recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2013
  6. 1729–1733. 6. Ivancic R, Iqbal H, deSilva B, Pan O, Matrka L. Current and future management of recurrent respiratory papillomatosis. Laryngoscope Investig Otolaryngol 2018
  7. Xu W, Han D, Hou L, Zhang L, Yu Z, Huang Z. Voice function following CO2 laser microsurgery for precancerous and early-stage glottic carcinoma. Acta Otolaryngol 2007
  8. 127(6):637–641. 8. Yan Y, Olszewski AE, Hoffman MR. Use of lasers in laryngeal surgery. J Voice 2010
  9. 24(1):102–109. 9. Coulombeau B, Nusa Naiman A, Ceruse P, Froehlich P. [Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis]. Rev Laryngol Otol Rhinol (Bord) 2002
  10. 123(5):315–320 10. Naiman AN, Ayari S, Nicollas R, Landry G, Colombeau B, Froehlich P. Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis. Ann Otol Rhinol Laryngol 2006
  11. 115(9):667–672. 11. Gazia F, Gallett B, Freni F, Bruno R, Sireci F, Galletti C, Meduri A, Galletti F. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literatüre. Eur Rev Med Pharmacol Sci. 2020
  12. 24(2):956-62. 12. Grasso M, Remacle M, Bachy V, Van Der Vorst S, Lawson G. Use of cidofovir in HPV patients with recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 2014
  13. 2990 13. Rahbar R, Vargas SO, Folkman J, et al: Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 114: 289-295, 2005. 14. Nagel S, Busch C, Blankenburg T and Schütte W: Treatment of respiratory papillomatosis - a case report on systemic treatment with bevacizumab. Pneumologie 63: